Premium
Setting up the first genitourinary clinic in Malta and an audit of the initial performance
Author(s) -
Schembri G.,
Carabot P.
Publication year - 2007
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/j.1468-3083.2007.02279.x
Subject(s) - medicine , audit , referral , condom , contact tracing , attendance , family medicine , syphilis , partner notification , asymptomatic , venereology , pediatrics , demography , human immunodeficiency virus (hiv) , psychiatry , management , disease , covid-19 , sociology , infectious disease (medical specialty) , economics , economic growth
Background The first genitourinary (GU) clinic was set up in Malta in January 2000. An audit was conducted to evaluate the demand for such a service and its effectiveness during the first 6 years after its introduction. Method Case notes from the first 6 years were reviewed, and data were collected for gender, age, sexual orientation, symptoms, diagnosis, condom use, referral source, total number of attendances, and contact tracing. Results The total number of attendances increased from 760 in the first year to 1832 in 2005. The male to female ratio decreased from 2.3 in 2000 to 1.6 in 2005, as more females attended. The number of partners treated per index case was 0.25. Eighty per cent of attendees were self‐referred; 16% were referred by their general practitioner (GP). Only 10% admitted to using a condom regularly. Twenty‐nine per cent of asymptomatic attendees in 2005 were diagnosed with a sexually transmitted infection (STI). Fifty‐three cases of gonorrhoea were diagnosed by the GU clinic during the first 6 years, with 17% of isolates showing resistance to ciprofloxacin in 2005. A total of 38 cases of syphilis were diagnosed compared to only a handful of cases reported in the 25 years prior to the introduction of the service. Conclusions The increasing attendance, as revealed by this audit, reflects a growing demand for the service offered by the GU clinic in Malta. Numerous STIs are being diagnosed and treated, including syphilis, which has re‐emerged in Malta as it has in the rest of Europe. The prevalence of ciprofloxacin‐resistant gonorrhoea has been increasing, a trend that has also been documented in other European countries. In addition to successful management of STIs, the GU clinic would further benefit from a public health campaign aimed at encouraging asymptomatic sexually active individuals to attend for an STI screen, while simultaneously promoting responsible sexual behaviour.